PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
VTRS vs. PFE
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


VTRSPFE
YTD Return23.17%-3.47%
1Y Return50.98%-4.10%
3Y Return (Ann)1.38%-15.57%
Sharpe Ratio1.55-0.24
Sortino Ratio2.45-0.18
Omega Ratio1.300.98
Calmar Ratio0.99-0.10
Martin Ratio3.87-0.72
Ulcer Index12.10%7.91%
Daily Std Dev30.27%24.12%
Max Drawdown-52.28%-54.82%
Current Drawdown-20.40%-51.03%

Fundamentals


VTRSPFE
Market Cap$15.43B$148.42B
EPS-$0.73$0.75
PEG Ratio0.080.69
Total Revenue (TTM)$15.02B$60.11B
Gross Profit (TTM)$6.07B$36.84B
EBITDA (TTM)$3.58B$15.48B

Correlation

-0.50.00.51.00.3

The correlation between VTRS and PFE is 0.33, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

VTRS vs. PFE - Performance Comparison

In the year-to-date period, VTRS achieves a 23.17% return, which is significantly higher than PFE's -3.47% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-10.00%-5.00%0.00%5.00%10.00%15.00%20.00%25.00%JuneJulyAugustSeptemberOctoberNovember
18.57%
-4.96%
VTRS
PFE

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

VTRS vs. PFE - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Viatris Inc. (VTRS) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


VTRS
Sharpe ratio
The chart of Sharpe ratio for VTRS, currently valued at 1.55, compared to the broader market-4.00-2.000.002.004.001.55
Sortino ratio
The chart of Sortino ratio for VTRS, currently valued at 2.45, compared to the broader market-4.00-2.000.002.004.006.002.45
Omega ratio
The chart of Omega ratio for VTRS, currently valued at 1.30, compared to the broader market0.501.001.502.001.30
Calmar ratio
The chart of Calmar ratio for VTRS, currently valued at 0.99, compared to the broader market0.002.004.006.000.99
Martin ratio
The chart of Martin ratio for VTRS, currently valued at 3.87, compared to the broader market0.0010.0020.0030.003.87
PFE
Sharpe ratio
The chart of Sharpe ratio for PFE, currently valued at -0.24, compared to the broader market-4.00-2.000.002.004.00-0.24
Sortino ratio
The chart of Sortino ratio for PFE, currently valued at -0.18, compared to the broader market-4.00-2.000.002.004.006.00-0.18
Omega ratio
The chart of Omega ratio for PFE, currently valued at 0.98, compared to the broader market0.501.001.502.000.98
Calmar ratio
The chart of Calmar ratio for PFE, currently valued at -0.10, compared to the broader market0.002.004.006.00-0.10
Martin ratio
The chart of Martin ratio for PFE, currently valued at -0.72, compared to the broader market0.0010.0020.0030.00-0.72

VTRS vs. PFE - Sharpe Ratio Comparison

The current VTRS Sharpe Ratio is 1.55, which is higher than the PFE Sharpe Ratio of -0.24. The chart below compares the historical Sharpe Ratios of VTRS and PFE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.50JuneJulyAugustSeptemberOctoberNovember
1.55
-0.24
VTRS
PFE

Dividends

VTRS vs. PFE - Dividend Comparison

VTRS's dividend yield for the trailing twelve months is around 3.71%, less than PFE's 6.41% yield.


TTM20232022202120202019201820172016201520142013
VTRS
Viatris Inc.
3.71%4.43%4.31%2.44%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
PFE
Pfizer Inc.
6.41%5.70%3.12%2.64%3.92%3.68%3.12%3.54%3.70%3.48%3.34%3.14%

Drawdowns

VTRS vs. PFE - Drawdown Comparison

The maximum VTRS drawdown since its inception was -52.28%, roughly equal to the maximum PFE drawdown of -54.82%. Use the drawdown chart below to compare losses from any high point for VTRS and PFE. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%JuneJulyAugustSeptemberOctoberNovember
-20.40%
-51.03%
VTRS
PFE

Volatility

VTRS vs. PFE - Volatility Comparison

Viatris Inc. (VTRS) has a higher volatility of 14.46% compared to Pfizer Inc. (PFE) at 4.54%. This indicates that VTRS's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%14.00%JuneJulyAugustSeptemberOctoberNovember
14.46%
4.54%
VTRS
PFE

Financials

VTRS vs. PFE - Financials Comparison

This section allows you to compare key financial metrics between Viatris Inc. and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items